Clinical Trials Are In Process To Bring The New Drug To Treat Fanconi Anemia

Fanconi Anemia is a blood disease that leads to bone marrow failure. It affects all systems of the body and prevents the diseased from reaching the adulthood.  The only long term cure available for Fanconi Anemia patients is bone bone marrow transplant from an exact-match sibling. The present treatment is associated with many risks. Clinical grade material will be prepared based on the Molecular and Cellular Therapeutics of University of Minnesota. The clinical trial is being directed by the experienced physicians in the world for the treatment of FA. The trial can be planned with low number of patients to complete the trail quickly at low cost.

The patient will be initially checked in the health center after which the patient’s bone marrow sample is taken. This will be followed up under the doctor’s observation.  Treated bone marrow cells are returned to the patient. SB- therurapic is delivered into patient’s bone marrow steam cells.